Atossa Therapeutics Inc.

NASDAQ: ATOS · Real-Time Price · USD
0.78
-0.00 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
0.78
-0.04%
After-hours: Aug 15, 2025, 04:04 PM EDT

Atossa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-25.5M -30.09M -26.96M -20.61M
Depreciation & Amortization
17K 23K 8K 23K
Stock-Based Compensation
2.29M 4.62M 6.79M 5.27M
Other Working Capital
1.19M 391K -1.85M -1.28M
Other Non-Cash Items
1.72M 2.99M 3K n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
448K 1.52M -599K -1.16M
Operating Cash Flow
-21.03M -20.94M -20.76M -16.47M
Capital Expenditures
-19K -14 -27K -9K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -4.7M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -13.99K n/a n/a
Investing Cash Flow
-19K -14K -4.73M -9K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -1.48K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -1.47M n/a 43.64M
Financial Cash Flow
3.67M -1.48M n/a 113.3M
Net Cash Flow
-17.38M -22.43M -25.49M 96.82M
Free Cash Flow
-21.05M -20.95K -20.79M -16.48M